CircRNAs in diabetic cardiomyopathy

Hengquan Wan,Simin Zhao,Qian Zeng,Yao Tan,Chi Zhang,Lingyun Liu,Shunlin Qu

DOI: https://doi.org/10.1016/j.cca.2021.03.001

IF: 6.314

2021-06-01

Clinica Chimica Acta

Abstract:<p>Diabetic cardiomyopathy is an important irreversible chronic cardiovascular complication in diabetic patients. This condition is described as early diastolic dysfunction, myocardial fibrosis, cardiac hypertrophy, systolic dysfunction and other complex pathophysiological events, which ultimately lead to heart failure. Despite these characteristics, the underlying mechanisms resulting in diabetic cardiomyopathy are still unknown. With the developments in molecular biotechnology, increasing evidence shows that circRNAs play critical roles in the pathogenesis of diabetic cardiomyopathy. The purpose of this review is to summarize recent studies on the role of circRNAs in the pathophysiological process to provide novel prevention and treatment strategies for diabetic cardiomyopathy, oxidative stress, inflammation, endothelial dysfunction, myocardial fibrosis and cell death in diabetic cardiomyopathy.</p>

medical laboratory technology